J. Jaubert

发表

Chlorambucil in indolent chronic lymphocytic leukemia. French Cooperative Group on Chronic Lymphocytic Leukemia.

K. Maloum, B. Cazin, M. Leporrier, 1998, The New England journal of medicine.

Achievement of VGPR to induction therapy is an important prognostic factor for longer PFS in the IFM 2005-01 trial.

D. Esseltine, B. Pégourié, B. Grosbois, 2011, Blood.

Randomized comparison of fludarabine, CAP, and ChOP in 938 previously untreated stage B and C chronic lymphocytic leukemia patients.

P. Feugier, S. Chevret, C. Chastang, 2001, Blood.

Comparison of 36 Gy, 20 Gy, or No Radiation Therapy After 6 Cycles of EBVP Chemotherapy and Complete Remission in Early-Stage Hodgkin Lymphoma Without Risk Factors: Results of the EORT-GELA H9-F Intergroup Randomized Trial.

D. de Jong, E. Noordijk, A. Stamatoullas, 2017, International journal of radiation oncology, biology, physics.

Chemotherapy plus involved-field radiation in early-stage Hodgkin's disease.

J. Raemaekers, A. Hagenbeek, G. Salles, 2007, The New England journal of medicine.

Long-term analysis of the IFM 99 trials for myeloma: cytogenetic abnormalities [t(4;14), del(17p), 1q gains] play a major role in defining long-term survival.

B. Pégourié, P. Moreau, F. Magrangeas, 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Heterogeneity of t(4;14) in multiple myeloma. Long-term follow-up of 100 cases treated with tandem transplantation in IFM99 trials

B. Grosbois, I. Yakoub-Agha, M. Mohty, 2007, Leukemia.

Bone marrow transplantation prolongs survival after relapse in aggressive-lymphoma patients treated with the LNH-84 regimen.

B. Coiffier, H. Tilly, C. Gisselbrecht, 1992, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Patients and Methods: the Act Ii Trial Recruited 940 Patients Comparing 5fu-based Crt Using Cisplatin (cisp)

J. Ledermann, O. Casasnovas, N. Mounier, 2022 .

Prognostic value of urinary pyridinium crosslinks and their derivatives in multiple myeloma

X. Leleu, J. Jamart, C. Mathiot, 2004, Annals of Hematology.

High-dose melphalan versus melphalan plus dexamethasone for AL amyloidosis.

F. Jardin, J. Piette, B. Grosbois, 2007, The New England journal of medicine.

Randomized Clinical Trial Comparing Melphalan-Prednisone (MP), MP-Thalidomide (MP-THAL) and High-Dose Therapy Using Melphalan 100 MG/M2 (MEL100) for Newly Diagnosed Myeloma Patients Aged 65–75 Years. Interim Analysis of the IFM 99-06 Trial on 350 Patients.

B. Pégourié, J. Mary, G. Guillerm, 2004 .

GOELAMS with final results after a median follow-up of 9 years advanced follicular lymphoma: a randomized multicenter study by the transplantation and doxorubicin-based chemotherapy in patients with High-dose therapy followed by autologous purged stem cell

E. Deconinck, P. Colombat, N. Milpied, 2013 .

High-dose therapy followed by autologous purged stem cell transplantation and doxorubicin-based chemotherapy in patients with advanced follicular lymphoma: a randomized multicenter study by the GOELAMS with final results after a median follow-up of 9 years.

E. Deconinck, P. Colombat, N. Milpied, 2009, Blood.

Timed sequential chemotherapy for previously treated patients with acute myeloid leukemia: long-term follow-up of the etoposide, mitoxantrone, and cytarabine-86 trial.

P. Fenaux, X. Thomas, X. Troussard, 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Expression and prognostic significance of Bcl‐2 family proteins in myelodysplastic syndromes

C. Vasselon, M. Bertheas, D. Boudard, 2002, American journal of hematology.

The position of the M‐BCR breakpoint does not predict the duration of chronic phase or survival in chronic myeloid leukaemia

P. Martiat, J. Goldman, N. Ifrah, 1990, British journal of haematology.

Hydroxyurea versus interferon alfa-2b in chronic myelogenous leukaemia: preliminary results of an open French multicentre randomized study.

C. Charrin, G. Marit, P. Bernard, 1991, European journal of cancer.

Four ABVD and Involved-Field Radiotherapy in Unfavorable Supradiaphragmatic Clinical Stages (CS) I-II Hodgkin’s Lymphoma (HL): Preliminary Results of the EORTC-GELA H9-U Trial.

A. Hagenbeek, R. Bouabdallah, F. Morschhauser, 2005 .

Sequential Chemotherapy with Mitoxantrone, Etoposide and Cytarabine for Previously Treated Acute Myeloid Leukemia: EMA 86 Regimen

P. Fenaux, X. Thomas, X. Troussard, 1996 .

[Gm allotype HLA antigens and T lymphocyte sub-populations in a group of patients having a positive Coombs test under treatment with alpha-methyldopa].

B. Pozzetto, J. L. le Petit, J. Jaubert, 1984, Revue francaise de transfusion et immuno-hematologie.

Deletion of the 1p32 region is a major independent prognostic factor in young patients with myeloma: the IFM experience on 1195 patients

B. Pégourié, C. Sebban, P. Moreau, 2014, Leukemia.

High efficacy with five days schedule of oral fludarabine phosphate and cyclophosphamide in patients with previously untreated chronic lymphocytic leukaemia

P. Feugier, S. Leprêtre, B. Grosbois, 2008, British journal of haematology.

A case of myelodysplastic syndrome with abnormal megakaryocytes and ins(8;3)(q24;q21q26).

C. Vasselon, M. Bertheas, J. Jaubert, 1991, Cancer genetics and cytogenetics.

A complex t(3;8;17) involving breakpoint 8p11 in a case of M5 acute nonlymphocytic leukemia with erythrophagocytosis.

A. Hagemeijer, J. L. le Petit, C. Vasselon, 1989, Cancer genetics and cytogenetics.

Prognostic value of high-sensitivity measurable residual disease assessment after front-line chemoimmunotherapy in chronic lymphocytic leukemia

Marc C. Jacob, M. Boubaya, J. Rossi, 2020, Leukemia.

t(2;18) and t(18;22) variant chromosomal translocations in B cell malignancies.

F. Berger, J. Magaud, R. Rimokh, 1992, Leukemia & lymphoma.

Idarubicin in the treatment of relapsed or refractory acute myeloid leukemia.

J. Reiffers, P. Hurteloup, P. Dufour, 1987, Cancer treatment reports.

Histologic evidence of an abnormal bone remodeling in b‐cell malignancies other than multiple myeloma

J. Rossi, R. Bataille, D. Chappard, 1988, Cancer.

Intensive sequential chemotherapy with mitoxantrone and continuous infusion etoposide and cytarabine for previously treated acute myelogenous leukemia.

P. Fenaux, E. Archimbaud, V. Leblond, 1991, Blood.

[Pyoderma gangrenosum aggravated by GM-CSF administration].

J. Perrot, A. Claudy, J. Jaubert, 1992, Annales de dermatologie et de vénéréologie.

Upfront VIP‐reinforced‐ABVD (VIP‐rABVD) is not superior to CHOP/21 in newly diagnosed peripheral T cell lymphoma. Results of the randomized phase III trial GOELAMS‐LTP95

J. Rossi, R. Gressin, E. Deconinck, 2010, British journal of haematology.

Melphalan and prednisone plus thalidomide versus melphalan and prednisone alone or reduced-intensity autologous stem cell transplantation in elderly patients with multiple myeloma (IFM 99–06): a randomised trial

B. Pégourié, B. Grosbois, I. Yakoub-Agha, 2007, The Lancet.

Hemoglobin Grange‐Blanche [β27(B9) Ala → Val], a new variant with normal expression and increased affinity for oxygen

J. Delaunay, A. Geyssant, A. Francina, 1987, FEBS letters.

Chlorambucil in Indolent Chronic Lymphocytic Leukemia

K. Maloum, B. Cazin, M. Leporrier, 1998 .

Massive therapy and autologous bone marrow transplantation in pediatric and young adults Burkitt's lymphoma (30 courses on 28 patients: a 5-year experience).

D. Frappaz, P. Biron, M. Favrot, 1986, European journal of cancer & clinical oncology.

High-dose therapy followed by autologous purged stem-cell transplantation and doxorubicin-based chemotherapy in patients with advanced follicular lymphoma: a randomized multicenter study by GOELAMS.

R. Gressin, E. Deconinck, P. Cornillet‐Lefèbvre, 2005, Blood.

MOLECULAR STUDY OF A VARIANT TRANSLOCATION t(2;18)(p11;q21) IN A FOLLICULAR LYMPHOMA

F. Berger, J. Magaud, R. Rimokh, 1991, British journal of haematology.

Transmission of leukemic donor cells by allogeneic stem cell transplantation in a context of familial CLL: should we screen donors for MBL?

M. Callanan, N. Nadal, J. Cornillon, 2010, Blood.

Intensive salvage therapy with high-dose chemotherapy for patients with advanced Hodgkin's disease in relapse or failure after initial chemotherapy: results of the Groupe d'Etudes des Lymphomes de l'Adulte H89 Trial.

G. Salles, F. Berger, A. Stamatoullas, 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

elderly multiple myeloma patients ineligible for high-dose therapy Dexamethasone-based regimens versus melphalan-prednisone for

J. Rossi, R. Bataille, I. Yakoub-Agha, 2011 .

Dexamethasone-based regimens versus melphalan-prednisone for elderly multiple myeloma patients ineligible for high-dose therapy

Augustin Ferrant, Chantal Doyen, J. Rossi, 2006 .

Prospective genetically randomized comparison between intensive postinduction chemotherapy and bone marrow transplantation in adults with newly diagnosed acute myeloid leukemia.

X. Thomas, E. Archimbaud, M. Michallet, 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Follicular large-cell lymphoma treated with intensive chemotherapy: an analysis of 89 cases included in the LNH87 trial and comparison with the outcome of diffuse large B-cell lymphoma. Groupe d'Etude des Lymphomes de l'Adulte.

P. Gaulard, B. Coiffier, J. Diebold, 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Major Superiority of Melphalan - Prednisone (MP) + Thalidomide (THAL) over MP and Autologous Stem Cell Transplantation in the Treatment of Newly Diagnosed Elderly Patients with Multiple Myeloma.

Brigitte Pegourie, J. Y. Mary, B. Pégourié, 2005 .

1p22 and 1p32 Deletions Are Independent Prognosis Factors in Young Patients with Myeloma: The IFM Experience On 1195 Patients

B. Pégourié, C. Sebban, P. Moreau, 2012 .

Maintenance with low-dose cytarabine for acute myeloid leukemia in complete remission

C. Sebban, X. Thomas, E. Archimbaud, 1992, Annals of Hematology.

Variant translocation in Burkitt's lymphoma: 8;22 translocation in a French patient with an Epstein-Barr virus-associated tumor.

G. Lenoir, C. Vasselon, G Lenoir, 1981, Cancer genetics and cytogenetics.

Chromosome studies in stimulated lymphocytes of 50 patients with B-cell chronic lymphocytic leukemia.

R. Rimokh, C. Vasselon, M. Bertheas, 1992, Nouvelle revue francaise d'hematologie.

ABVD (8 cycles) versus BEACOPP (4 escalated cycles ≥ 4 baseline): final results in stage III-IV low-risk Hodgkin lymphoma (IPS 0-2) of the LYSA H34 randomized trial.

O. Casasnovas, N. Mounier, M. André, 2014, Annals of oncology : official journal of the European Society for Medical Oncology.

Autologous Stem Cell Transplantation (ASCT) Versus Oral Melphalan and High-Dose Dexamethasone in Patients with AL (Primary) Amyloidosis: Results of the French Multicentric Randomized Trial (MAG and IFM Intergroup).

B. Grosbois, M. Cogné, P. Preux, 2005 .

Sideroblastic anaemia during fusidic acid treatment

M. Ruivard, C. Guy, T. Vial, 2004, European journal of haematology.

Clinical and pharmacokinetic phase II study of fotemustine in refractory and relapsing multiple myeloma patients.

B. Coiffier, C. Sebban, C. Dumontet, 2003, Annals of oncology : official journal of the European Society for Medical Oncology.

Kinetic of circulating antigens by capture ELISA and immunoblotting in murine toxoplasmosis.

B. Pozzetto, J. Hafid, M. Jana, 1991, European journal of protistology.

Clinical Trials and Observations

C. Bloomfield, L. Staudt, A. Rosenwald, 2005 .

Upfront VIP‐reinforced‐ABVD (VIP‐rABVD) is not superior to CHOP/21 in newly diagnosed peripheral T cell lymphoma. Results of the randomized phase III trial GOELAMS‐LTP95

J. Rossi, R. Gressin, E. Deconinck, 2010, British journal of haematology.

Tumour-and treatment-related colostomy rates following mitomycin C or cisplatin chemoradiation with or without maintenance chemotherapy in squamous cell carcinoma of the anus in the ACT II trial †

O. Casasnovas, A. Delmer, C. Humbrecht, 2014 .

Tumour-and treatment-related colostomy rates following mitomycin C or cisplatin chemoradiation with or without maintenance chemotherapy in squamous cell carcinoma of the anus in the ACT II trial †

O. Casasnovas, N. Mounier, A. Delmer, 2014 .

Dexamethasone-based regimens versus melphalan-prednisone for elderly multiple myeloma patients ineligible for high-dose therapy.

B. Pégourié, B. Grosbois, J. Mary, 2006, Blood.